Ignite Creation Date:
2025-12-24 @ 7:14 PM
Ignite Modification Date:
2025-12-25 @ 4:50 PM
Study NCT ID:
NCT05114603
Status:
UNKNOWN
Last Update Posted:
2022-05-03
First Post:
2021-10-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase II Clinical Trial to Evaluate HLX208 in Advanced Melanoma Patients With BRAF V600 Mutation
Sponsor:
Shanghai Henlius Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-21
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-29
First Submit QC Date:
None
Study First Post Date:
2021-11-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-01
Last Update Post Date:
2022-05-03
Last Update Post Date Type:
ACTUAL